Tekla Capital Management LLC Fulcrum Therapeutics, Inc. Transaction History
Tekla Capital Management LLC
- $2.53 Billion
- Q2 2023
A detailed history of Tekla Capital Management LLC transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 256,888 shares of FULC stock, worth $1.59 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
256,888
Previous 58,537
338.85%
Holding current value
$1.59 Million
Previous $166,000
410.24%
% of portfolio
0.03%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding FULC
# of Institutions
136Shares Held
43.7MCall Options Held
3.12MPut Options Held
128K-
Rtw Investments, LP New York, NY5.85MShares$36.2 Million0.89% of portfolio
-
Cowen And Company, LLC3.71MShares$23 Million1.18% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.85MShares$17.7 Million1.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.54MShares$15.7 Million0.0% of portfolio
-
Trv Gp Iv, LLC Boston, MA2.34MShares$14.5 Million10.72% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $323M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...